share_log

IGM Biosciences Q1 EPS $(0.83), Inline, Sales $497.00K Miss $760.00K Estimate

Benzinga ·  May 8 18:10

IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is a 37.59 percent increase over losses of $(1.33) per share from the same period last year. The company reported quarterly sales of $497.00 thousand which missed the analyst consensus estimate of $760.00 thousand by 34.61 percent. This is a 4.79 percent decrease over sales of $522.00 thousand the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment